Thromb Haemost 1957; 01(03/04): 471-481
DOI: 10.1055/s-0038-1656214
Originalarbeiten – Original Article – Travaux Originaux
Schattauer GmbH

Blood Coagulation as a Continuous Process[*)]

J Roos
1   Medical Department, University Hospital, Utrecht, Holland
› Author Affiliations
Further Information

Publication History

Publication Date:
05 June 2018 (online)

Summary

In order to study the phenomenon of spontaneous hemorrhages in cases of diminished clotting power, we performed an investigation with the aid of the electron-microscope by means of a replica technique, on the aspect of aorta endothelium in two groups of rabbits, the first with a normal clotting power, the second with a hypocoagulability. Comparison of these two groups revealed two points of discrepancy. In the first place, in all the preparations of normal rabbits we saw fibres lying perpendicular to the borderlines of endothelial cells. These fibres were hardly seen under conditions of hypocoagulability, which is one of the arguments for equating these filaments with fibrin. In the second place, the nuclei of endothelial cells were less prominent into the vascular lumen in hypocoagulability than in cases of normal clotting power. From these observations and from some theoretical arguments we came to the hypothesis that blood coagulation is a continuous process which lays down fibrin fibres on the endothelium and which influences the swelling of the cytoplasm of endothelial cells. We could not get more information concerning the problem of how erythrocytes can penetrate endothelium in cases of hypocoagulability by studying the aspect of the blood-urine barrier in the glomeruli in the same two groups of rabbits.

* This investigation was supported by a grant from Eli Lilly and Compagny, Indianapolis U.S.A.


 
  • References

  • 1 Aboulker P, Soulier J. P, et Larrieu M. J. Syndrome hémorragique avec fibrinolyse associé au cancer de la prostate. Presse méd. 63: 353 1955;
  • 2 Alexander B. Coagulation, hemorrhage and thrombosis. New Engl. J. Med. 252:432/484/526 1955
  • 3 Astrup T. Fibrinolysis in the organism. Blood 11: 781 1956;
  • 4 Bennike T, and MüHertz S. Flaemorrhagic diathesis associated with fibrinogeno-penia and fibrinolysis. Acta Haemat. 8: 147 1952;
  • 5 Boyd W. A textbook of pathology. Lea & Febiger; Philadelphia: 1947
  • 6 Copley A. L. Effet capilloragique de la fibrinolysine. Arch. int. Pharmacodyn. 99: 426 1954;
  • 7 Duguid J. B. Mural thrombosis in arteries. Brit. Med. Bull. 11: 36 1955;
  • 8 Eichenberger E, und Schmidhauser-Kopp M. Thrombelastographische Untersuchungen über die Fibrinolyse. Helv. physiol. pharmacol. Acta 12: C69 1954;
  • 9 Elbers P. F. To be published
  • 10 Fearnley G. R, and Lackner R. The fibrinolytic activity of normal blood. Brit. J. Haemat. 1: 189 1955;
  • 11 Frick P. G. Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma. Am. J. Clin. Pathol. 25: 1263 1955;
  • 12 Gehmacher K, Herold G, und Reimer E. E. Gerinnungsstörung beim Plasmozytom. Wien. 2. Inn. Med. 35: 245 1954;
  • 13 Gitiin D, and Borges W. H. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood 8: 679 1953;
  • 14 Greig H. B. W. Inhibition of fibrinolysis by alimentary lipaemia. Lancet 2: 16 1956;
  • 15 Jensen H, Gray E, and Schaefer E. H. Formation of blood thrombokinase. Acta Haemat. 13: 377 1955;
  • 16 Jordan F. L. J. Symptomenleer en differentiële diagnostiek. Bijleveld; Utrecht: 199 1950
  • 17 Jürgens R, und Studer A. Zur Wirkung des Thrombins. Helv. physiol. pharmacol. Acta 6: 130 1948;
  • 18 König G, und Heiwig G. Über dünne aus Kohlenwasserstoffen durch Elektronen-und Ionenbeschuβ gebildete Schichten. Zschr. f. Physik 129: 491 1951;
  • 19 Laki K. The clotting of fibrinogen. Blood 8: 845 1953;
  • 20 Lasch H. G. Hemorrhage in liver disease. 6th Congress Int. Soc. Hematology Boston: 388 1956
  • 21 Levene C. I. The electron-microscopy of atheroma. Lancet 2: 1216 1955;
  • 22 Lüscher E, und Labhart A. Blutgerinnungsstörung durch βγ-Globuline. Schweiz. Med. Wschr. 79: 598 1949;
  • 23 Macfarlane R. G. Discussion on the factors concerned in blood coagulation and their clinical significance. Proc. Roy. Soc. Med. 38: 399 1945;
  • 24 Madden R. E, and Gould R. G. The turnover rate of fibrinogen in the dog. J. Biol. Chem. 196: 641 1952;
  • 25 Nilsson I. M, and Wenckert A. Demonstration of a heparinlike anticoagulant in normal blood. Acta Med. Scand.. Suppl. 297. 1954
  • 26 Palade G. E. A study of fixation for electron microscopy. J. Exp. Med. 95: 285 1952;
  • 27 Rhodin J. Correlation of ultrastructural organization and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney. Aktibolaget Godvil, Stockholm, 1954
  • 28 Roos J. Purpura Hypocoagulabilica. Thesis Utrecht 1957
  • 29 Spaet Th. H. Vascular factors in the pathogenesis of haemorrhagic syndromes. Blood 7: 641 1952;
  • 30 Sternberger L. A. Preliminary clinical evaluation of thrombin recovery test. J. Amer. med. Ass. 150: 1591 1952;
  • 31 Tagnon H. J, Whitmore W. F, Shulman P, and Kravitz S. C. The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate. Cancer 6: 63 1953;
  • 32 Uehlinger E. Über eine Blutgerinnungsstörung bei Dysproteinämie (Beitrag zur Kenntnis der körpereigenen Antikoagulantia). Helv. med. Acta 16: 508 1949;
  • 33 van Zandt Hawn C, and Porter K. R. The fine structure of clots formed from purified bovine fibrinogen and thrombin: a study with the electron microscope. J. exp. Med. 86: 285 1947; /
  • 34 Zweifach B. W. Structural makeup of capillary wall. Ann. N. Y. Acad. Sci. 61: 670 1955;